 |
N-{3-[(2-{[4-(4-acetylpiperazin-l-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl)amino]phenyl}prop-2-enamide |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer and mutations in the epidermal growth factor receptor |
| USA Market Approval | USA |
| USA Designation Date | 2013-05-14 00:00:00 |
| Sponsor | Clovis Oncology, Inc.;2525 28th Street, Suite 100;Boulder, CO, 80301 |
